Related Experiment Video

Updated: Jul 21, 2026

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

[The possibilities of using the newest experimental results in the progressive myopia treatment]

D Czepita1

  • 1Katedry Okulistyki, Pomorskiej AM w Szczecinie.

Klinika Oczna
|July 27, 1999
PubMed

Insights

This study reviews experimental myopia, detailing eye changes and identifying substances like atropine that may inhibit its progression. These findings offer potential therapeutic strategies for treating progressive myopia.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Experimental Biology

Context:

  • Myopia, a common visual impairment, poses a significant public health challenge.
  • Understanding the pathomechanism of myopia is crucial for developing effective treatments.
  • Experimental models provide valuable insights into myopia development and progression.

Purpose:

  • To review recent experimental findings on the pathomechanism of myopia.
  • To describe anatomical, physiological, and biochemical changes in experimental myopia.
  • To highlight pharmacological agents that inhibit experimental myopia progression.

Summary:

  • Discusses recent experimental results on myopia pathomechanism.
  • Details anatomical, physiological, and biochemical changes in experimental myopia.
  • Focuses on inhibiting substances such as apomorphine, reserpine, 6-hydroxydopamine, atropine, pirenzepine, chlorpyrifos, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid, kainic acid, naloxane, formoguanamine, gentamicin, sodium iodate, vasoactive intestinal polypeptide antagonists, and basic fibroblast growth factor.

Impact:

  • Identifies key substances with potential to inhibit myopia progression.
  • Suggests therapeutic possibilities for treating progressive myopia using identified agents.
  • Provides a foundation for further research into novel myopia treatments.

More Related Videos

Inducement and Evaluation of a Murine Model of Experimental Myopia07:20

Inducement and Evaluation of a Murine Model of Experimental Myopia

Published on: January 22, 2019

Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile05:46

Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile

Published on: September 20, 2024

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...